Two female scientists dedicated to developing new advancements in medicine.
A group of young adults practicing yoga outside, feeling confident, connected and healthy.
A male and female scientist examine a test tube to asses a breakthrough that could transform current treatment paradigms.
A middle-aged woman and her young daughter happily spending time together outside.
Two female scientists dedicated to creating a breakthrough treatment that could change the lives of patients.
A young father laughs with joy as he plays with his ballerina daughter and lifts her high into the air.
A three-dimensional rendering of a monoclonal antibody (mAb).

Our pivotal-stage monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP), and is currently in late-stage clinical development for the prevention of migraine.


A tablet on a stack of newspapers displaying the Alder BioPharmaceuticals website.

Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOTHELL, Wash. , May 24, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies... LEARN MORE

CONTACT US General inquiries:
Click here

ADDRESS & PHONE / FAX Corporate Headquarters
Alder BioPharmaceuticals, Inc.
11804 North Creek Parkway South
Bothell, WA 98011

Phone: 425-205-2900
Fax: 425-205-2901